Thus, the above experimental results indicate that in the context of the anti-CD47 Ab treatment of tumors, anti-CD47 Ab promoted tumor vascular normalization by increasing the infiltration of CD4+ T cells. The gene discussed is CD47; the disease is neoplasm.